Keyphrases
Surfactant Protein A (SP-A)
100%
Single nucleotide Polymorphism
51%
Protein-coding Genes
48%
Alveolar Macrophages
22%
Genetic Variants
20%
Acute Respiratory Failure
15%
SNP
14%
Preterm Infants
14%
Respiratory Syncytial Virus
13%
SFTPA2
13%
Surfactant Protein A2
13%
Term Newborn
12%
Respiratory Distress Syndrome
12%
Klebsiella Pneumoniae (K. pneumoniae)
12%
Meconium Aspiration Syndrome
12%
Hypersensitivity Pneumonitis
12%
Macrophages
12%
Infections in children
12%
Respiratory Syncytial Virus Infection
12%
Influenza-like Illness
11%
SFTPA1
10%
SPA2
10%
SPA1
10%
Interaction Model
9%
Sex Differences
9%
Influenza Virus
8%
A2 Protein
8%
COVID-19
8%
Sex-dependent
7%
SFTPC
7%
Sex-specific
7%
Pediatric
7%
Respiratory Morbidity
7%
Healthy children
6%
Gene Polymorphism
6%
Pathogenic Mechanism
6%
Decreased Risk
6%
Innate Immunity
6%
SFTPD
6%
Gene Expression Network
6%
Posterior Fossa Hemorrhage
6%
Ozone Exposure
6%
Gonadal Hormones
6%
Differential Impact
6%
Potential Exposure
6%
Alveolar Epithelial Cells
6%
Influenza Vaccine
6%
Severe Acute Respiratory Syndrome
6%
Respiratory Distress
6%
Bronchoalveolar Lavage
6%
Biochemistry, Genetics and Molecular Biology
Surfactant Protein
64%
Single-Nucleotide Polymorphism
47%
Surfactant Protein A
34%
Alveolar Macrophage
20%
Genetic Divergence
18%
Erethism
12%
Klebsiella pneumoniae
12%
Human Respiratory Syncytial Virus
12%
SFTPA2
12%
Single Nucleotide Polymorphism
9%
Sex Difference
9%
Haplotype
7%
Gene Expression
7%
Gene Polymorphism
7%
Knockout Mouse
6%
Influenza A Virus
6%
Isoform
6%
Macrophage
6%
